Ceritinib D7
{[allProObj[0].p_purity_real_show]}
货号：A1230191
同义名：
LDK378 d7
Ceritinib D7 是一种选择性、口服有效且具有ATP竞争性的ALK 酪氨酸 激酶抑制剂，适用于ALK 相关的癌症治疗研究。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type HazMat fee for 500 gram (Estimated) Excepted Quantity USD 0.00 Limited Quantity USD 15-60 Inaccessible (Haz class 6.1), Domestic USD 80+ Inaccessible (Haz class 6.1), International USD 150+ Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+ Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Ceritinib D7 化学结构
Ceritinib D7 3D分子结构
规格
价格
会员价
库存
数量
{[ item.pr_size ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]}
{[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}
现货
咨询
-
+
Ceritinib D7 纯度/质量文件 产品仅供科研
货号：A1230191
标准纯度：
{[allProObj[0].p_purity_real_show]}
产品说明书
全球学术期刊中引用的产品
• Cell Host Microbe , 2024. Ambeed. A163338
]
• Cancer Res. , 2024. Ambeed. A295334
]
• J. Pharm. Investig. , 2024. Ambeed. A221527 ,
A691302 ,
A272538 ,
A187261
]
• J. Fungi , 2024, 10(11): 751. Ambeed. A796919
]
• JBC , 2024, 107935. Ambeed. 更多 >
Ceritinib D7 质控信息
ASP3026
+
99%+
ALK-IN-1
++++
98+%
Crizotinib
++++
ALK, IC50: 24 nM
ROS1, Ki: <0.025 nM
98%
Entrectinib
✔
99%+
Brigatinib
+++
ROS1, IC50: 1.9 nM
ALK, IC50: 0.37 nM
FLT3
98%
NVP-TAE 684
+
99%+
Alectinib
++
ALK (F1174L), IC50: 3.5 nM
ALK, IC50: 1.9 nM
98%
Ceritinib
+++
IGF-1R,Insulin Receptor
98%
GSK1838705A
+++
IGF-1R,Insulin Receptor
99%
AZD-3463
++
IGF-1R
99%
Lorlatinib
++++
ALK (L1196M), Ki: 0.07 nM
ROS1, Ki: <0.07 nM
98%
Repotrectinib
+
ALK(L1196M), IC50: 1.01 nM
ALK(G1202R), IC50: 1.26 nM
Src
99%
Belizatinib
++
99%+
展开
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。
BMS-536924
++
+++
Insulin Receptor, IC50: 73 nM
MEK,FAK
98%
GSK1904529A
+++
+++
Insulin Receptor, IC50: 25 nM
98+%
Picropodophyllin
++++
99%+
NVP-AEW541
++
++
Insulin Receptor, IC50: 0.14 μM
FLT3
99%+
NVP-ADW742
+
99%
GSK1838705A
+++
++++
Insulin Receptor, IC50: 1.6 nM
ALK
99%
BMS-754807
++++
++++
Insulin Receptor, IC50: 1.7 nM
99%+
Linsitinib
+++
++
Insulin Receptor, IC50: 75 nM
99%+
AG1024
+
+
Insulin Receptor, IC50: 57 μM
98%
PQ401
+
99%+
展开
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。
Ceritinib D7 实验方案
计算器
摩尔计算器
总药量计算器
工作液计算器
存储液制备
1mg
5mg
10mg
1 mM
5 mM
10 mM
1.77mL
0.35mL
0.18mL
8.85mL
1.77mL
0.88mL
17.69mL
3.54mL
1.77mL
Ceritinib D7 技术信息
搜索
HazMat Fee +
